DF
UTHR icon

Dunhill Financial’s United Therapeutics UTHR Stock Holding History

Dunhill Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.3K Hold
55
– – 0.01% 419
2026
Q1 		$33.1K Buy
55
+4
+8% +$1.99K 0.01% 361
2025
Q4 		$24.8K Buy
51
+1
+2% +$466 0.01% 367
2025
Q3 		$21K Hold
50
– – 0.01% 355
2025
Q2 		$14.4K Hold
50
– – ﹤0.01% 383
2025
Q1 		$15.4K Sell
50
-50
-50% -$17.1K 0.01% 332
2024
Q4 		$35.3K Buy
100
+50
+100% +$18.4K 0.02% 212
2024
Q3 		$17.9K Buy
+50
New +$16.9K 0.01% 287

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dunhill Financial's UTHR Position: Q2 2026 in Review

Dunhill Financial held its United Therapeutics (UTHR) position steady in Q2 2026 at 55 shares worth $30.3K. The position accounts for 0.01% of the portfolio, ranked #419.

Dunhill Financial first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $35.3K in Q4 2024. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Dunhill Financial held 55 shares of United Therapeutics worth $30.3K as of Q2 2026.
  • Dunhill Financial left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #419 holding.
  • Dunhill Financial first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Dunhill Financial's United Therapeutics position peaked at $35.3K in Q4 2024.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.